Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (281-290 of 341) with videos related to

Pageof 35
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.
Rheumatology (Oxford, England)|April 22, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Kidney International Reports|April 11, 2018
The European Vasculitis Society 2016 Meeting ReportIngeborg M Bajema, Jan A Bruijn, Alina Casian, et al.
Rheumatology (Oxford, England)|May 27, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
The Lancet. Gastroenterology & Hepatology|July 21, 2025
Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trialDavid Jayne, Julie Croft, Neil Corrigan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority TrialPaul A Brogan, Barbara Arch, Helen Hickey, et al.
The Journal of Rheumatology|December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification CriteriaSindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
Annals of the Rheumatic Diseases|January 30, 2019
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosusSara K Tedeschi, Sindhu R Johnson, Dimitrios T Boumpas, et al.
Pageof 35

Showing results (281-290 of 341) with videos related to

Sort By:
Pageof 35
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.
Rheumatology (Oxford, England)|April 22, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Kidney International Reports|April 11, 2018
The European Vasculitis Society 2016 Meeting ReportIngeborg M Bajema, Jan A Bruijn, Alina Casian, et al.
Rheumatology (Oxford, England)|May 27, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
The Lancet. Gastroenterology & Hepatology|July 21, 2025
Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trialDavid Jayne, Julie Croft, Neil Corrigan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority TrialPaul A Brogan, Barbara Arch, Helen Hickey, et al.
The Journal of Rheumatology|December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification CriteriaSindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
Annals of the Rheumatic Diseases|January 30, 2019
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosusSara K Tedeschi, Sindhu R Johnson, Dimitrios T Boumpas, et al.
Pageof 35